Breaking News Instant updates and real-time market news.

2020-11-20 11:56:42 ABB ABB $26.63 / -0.3 (-1.11%) 11:56 11/20/20 11/20 11:56 11/20/20 11:56	ABB price target raised to CHF 22 from CHF 21.50 at JPMorgan JPMorgan analyst Andreas Willi raised the firm's price target on ABB to CHF 22 from CHF 21.50 and keeps an Underweight rating on the shares.
ABB ABB $26.63 / -0.3 (-1.11%) 11/20/20 Deutsche Bank ABB downgraded to Sell from Hold at Deutsche Bank 10/26/20 JPMorgan ABB price target raised to CHF 21.50 from CHF 20 at JPMorgan 10/26/20 Morgan Stanley ABB price target raised to CHF 19.40 from CHF 18 at Morgan Stanley 08/20/20 Berenberg ABB initiated with a Sell at Berenberg

2020-11-20 11:56:42

ABB

$26.63 / -0.3 (-1.11%)

11:56

11/20/20

11/20

11:56

11/20/20

11:56

ABB price target raised to CHF 22 from CHF 21.50 at JPMorgan

JPMorgan analyst Andreas Willi raised the firm's price target on ABB to CHF 22 from CHF 21.50 and keeps an Underweight rating on the shares.

ABB ABB

$26.63 / -0.3 (-1.11%)

11/20/20 Deutsche Bank: ABB downgraded to Sell from Hold at Deutsche Bank

10/26/20 JPMorgan: ABB price target raised to CHF 21.50 from CHF 20 at JPMorgan

10/26/20 Morgan Stanley: ABB price target raised to CHF 19.40 from CHF 18 at Morgan Stanley

08/20/20 Berenberg: ABB initiated with a Sell at Berenberg

TODAY'S FREE FLY STORIES

Options	SunPower call volume above normal and directionally bullish » 13:45 01/22/21 01/22 13:45 01/22/21 13:45 SPWR SunPower $45.51 / +1.76 (+4.02%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SPWR SunPower $45.51 / +1.76 (+4.02%) 01/07/21 SunPower closing manufacturing facility in Hillsboro, Oregon 01/07/21 Hannon Armstrong announces leadership moves, promotes Jeffrey Lipson to COO 08/27/20 Total 'fully supports' SunPower spin-off of Maxeon Solar 08/27/20 SunPower, Maxeon Solar complete spin-off transaction SPWR SunPower $45.51 / +1.76 (+4.02%) 01/20/21 JPMorgan SunPower price target raised to $25 from $21 at JPMorgan 01/20/21 Credit Suisse SunPower price target raised to $23 from $16 at Credit Suisse 01/19/21 Piper Sandler SunPower price target raised to $35 from $22 at Piper Sandler 01/12/21 Fly Intel: Top five analyst initiations SPWR SunPower $45.51 / +1.76 (+4.02%) 10/28/20 SunPower raises 2020 non-GAAP revenue view to $1.12-$1.16B from $1.06B-$1.10B 10/28/20 SunPower still sees Q4 revenue $330M-$370M, consensus $350.28M 10/28/20 SunPower reports Q3 non-GAAP EPS (4c), consensus (5c) 10/28/20 Notable companies reporting after market close SPWR SunPower $45.51 / +1.76 (+4.02%) 11/11/20 Former Google exec seen as 'top' Biden energy pick, Bloomberg reports SPWR SunPower $45.51 / +1.76 (+4.02%) 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 03/15/21 33rd Annual Roth Virtual Conference SPWR SunPower $45.51 / +1.76 (+4.02%) 01/14/21 SunPower call volume above normal and directionally bullish 11/04/20 Unusually active option classes on open November 4th 11/03/20 SunPower put volume heavy and directionally bearish 10/20/20 SunPower call volume above normal and directionally bullish
Initiation	CyberAgent initiated with a Neutral at Goldman Sachs » 13:43 01/22/21 01/22 13:43 01/22/21 13:43 CYAGF CyberAgent $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CYAGF CyberAgent $0.00 / + (+0.00%) 04/07/20 Jefferies CyberAgent downgraded to Hold from Buy at Jefferies
General news	Oil Action: The weekly Baker Hughes oil rig count » 13:35 01/22/21 01/22 13:35 01/22/21 13:35 Oil Action: The weekly… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	AIkido Pharma regains compliance with Nasdaq listing requirements » 13:32 01/22/21 01/22 13:32 01/22/21 13:32 AIKI AIkido Pharma $1.18 / -0.035 (-2.88%) AIkido Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News AIKI AIkido Pharma $1.18 / -0.035 (-2.88%) 01/06/21 AIkido Pharma executes licensing agreement for psilocybin in cancer applications 12/09/20 AIkido Pharma announces AI/ML publication in field of pancreatic cancer 11/13/20 AIkido Pharma reports positive results of licensed antiviral platform 10/28/20 AIkido Pharma issues update on preclinical work on DHA-dFdC
Initiation	Z Holdings initiated with a Buy at Goldman Sachs » 13:29 01/22/21 01/22 13:29 01/22/21 13:29 YAHOY Z Holdings $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Recommendations	Bankinter price target raised to EUR 5.35 from EUR 5.25 at Deutsche Bank » 13:26 01/22/21 01/22 13:26 01/22/21 13:26 BKIMF Bankinter $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 01/20/21 UBS Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays
Recommendations	Hargreaves Lansdown price target raised to 1,700 GBp at Deutsche Bank » 13:25 01/22/21 01/22 13:25 01/22/21 13:25 HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) 11:53 Today Canaccord Hargreaves Lansdown price target raised to 1,695 GBp at Canaccord 01/12/21 Morgan Stanley Hargreaves Lansdown price target raised to 1,427 GBp at Morgan Stanley 01/12/21 JPMorgan Hargreaves Lansdown price target raised to 1,450 GBp from 1,390 GBp at JPMorgan 01/08/21 Barclays Hargreaves Lansdown price target lowered to 1,925 GBp at Barclays
Options	Camping World call volume above normal and directionally bullish » 13:25 01/22/21 01/22 13:25 01/22/21 13:25 CWH Camping World $35.85 / +0.91 (+2.60%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CWH Camping World $35.85 / +0.91 (+2.60%) 12/16/20 Camping World, Lordstown Motors partner on EV service network 11/24/20 Camping World acquires Paul Sherry RV in Piqua Ohio 11/19/20 Camping World to acquire All RV Needs in Oregon 11/18/20 Camping World declares quarterly and special dividend totaling $1.00 per share CWH Camping World $35.85 / +0.91 (+2.60%) 01/20/21 Monness Crespi Peer's results show positive read-through for Camping World, says Monness Crespi 12/16/20 JPMorgan JPMorgan reiterates $45 target on Camping World after Lordstown pact 11/04/20 BMO Capital Camping World price target lowered to $30 from $36 at BMO Capital 09/28/20 JPMorgan RV shipments rose for third straight month in August, says JPMorgan CWH Camping World $35.85 / +0.91 (+2.60%) 11/02/20 Camping World CEO confirms previously issued FY21 adjusted EBITDA target 11/02/20 Camping World raises FY20 adjusted EBITDA view to $495M-$515M from $460M-$490M 11/02/20 Camping World reports Q3 EPS $1.44, consensus 96c 08/05/20 Camping World sees 2020 as company's 'most profitable' year ever 20 Aug CWH Camping World $35.85 / +0.91 (+2.60%) 12/15/20 Lordstown, Camping World to make 'special announcement,' WKBN says CWH Camping World $35.85 / +0.91 (+2.60%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades 11/02/20 Fly Intel: Wall Street's top stories for Monday 11/02/20 Fly Intel: Wall Street's top stories at midday 02/25/21 Camping World - CWH CWH Camping World $35.85 / +0.91 (+2.60%) 01/21/21 Camping World call volume above normal and directionally bullish 12/16/20 Call trader flips Camping World calls for 1day loss 12/16/20 Unusually active option classes on open December 16th 12/15/20 Camping World call volume above normal and directionally bullish
Recommendations	PSP Swiss Property price target raised to CHF 120 from CHF 103 at Deutsche Bank » 13:24 01/22/21 01/22 13:24 01/22/21 13:24 PSPSF PSP Swiss Property $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PSPSF PSP Swiss Property $0.00 / + (+0.00%) 08/21/20 JPMorgan PSP Swiss Property upgraded to Neutral from Underweight at JPMorgan 08/19/20 Deutsche Bank PSP Swiss Property price target raised to CHF 103 from CHF 102 at Deutsche Bank 06/09/20 Berenberg PSP Swiss Property price target lowered to CHF 130 from CHF 132 at Berenberg 05/11/20 Morgan Stanley PSP Swiss Property price target lowered to CHF 90 at Morgan Stanley
Recommendations	Entain price target raised to 1,601 GBp from 1,351 GBp at Deutsche Bank » 13:22 01/22/21 01/22 13:22 01/22/21 13:22 GMVHF Entain $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GMVHF Entain $0.00 / + (+0.00%) 01/19/21 Entain responds to MGM announcement, looks forward to continuing JV success 01/19/21 MGM Resorts jumps 6% to $31.50 after announcing it won't bid for Entain 01/19/21 MGM Resorts says will not make a firm offer for Entain 01/11/21 Washington Nationals, BetMGM announce multi-year partnership GMVHF Entain $0.00 / + (+0.00%) 01/19/21 Berenberg Entain price target raised to 1,730 GBp from 1,175 GBp at Berenberg 01/19/21 Macquarie MGM walking away from Entain shows discipline, says Macquarie 01/19/21 Jefferies Entain remains 'highly attractive' after MGM doesn't bid, says Jefferies 01/19/21 Berenberg Entain price target raised to 1,730 GBp from 1,175 GBp at Berenberg GMVHF Entain $0.00 / + (+0.00%) 01/03/21 MGM makes new offer to acquire gaming company Entain, WSJ reports GMVHF Entain $0.00 / + (+0.00%) 01/19/21 DraftKings slips as analyst says sell on 'overoptimistic' share estimates 01/08/21 Bet On It: New York warming up to online sports betting 12/04/20 Bet On It: Michigan clears path for online gambling 10/16/20 Friday Parlay: NJ results seen as push on prospective states toward legalization

Recommendations	Commerzbank price target raised to EUR 6 from EUR 4 at Deutsche Bank » 13:22 01/22/21 01/22 13:22 01/22/21 13:22 CRZBY Commerzbank $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRZBY Commerzbank $0.00 / + (+0.00%) 09/28/20 Deutsche Bank's Manfred Knof named as new Commerzbank CEO 08/03/20 Commerzbank names Hans-Joerg Vetter chairman of the board CRZBY Commerzbank $0.00 / + (+0.00%) 01/20/21 RBC Capital Commerzbank price target raised to EUR 6.50 from EUR 5.50 at RBC Capital 11/06/20 Credit Suisse Commerzbank price target lowered to EUR 5 from EUR 5.10 at Credit Suisse 10/16/20 Credit Suisse Commerzbank initiated with a Neutral at Credit Suisse 09/14/20 UBS Commerzbank downgraded to Sell from Neutral at UBS CRZBY Commerzbank $0.00 / + (+0.00%) 01/13/21 UniCredit considers Orcel, Thiam for CEO role, FT reports
Hot Stocks	Bristol-Myers announces approval of Opdivo plus Cabometyx for carcinoma » 13:21 01/22/21 01/22 13:21 01/22/21 13:21 BMY Bristol-Myers $64.78 / +0.59 (+0.92%) Bristol Myers Squibb… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 Bristol-Myers: FDA accepts for Priority Review sBLA for Opdivo combination 01/11/21 Bristol-Myers CEO: Our strategy for growth is based on innovation 01/11/21 Illumina announces new and expanded oncology partnerships 01/11/21 Bristol-Myers announces $2B incremental share repurchase plan BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 01/20/21 Citi Citi opens 'negative Catalyst Watch' on Bristol-Myers 12/15/20 Goldman Sachs Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs 12/09/20 Mizuho Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 11/05/20 Bristol-Myers backs FY21 EPS view $7.15-$7.45, consensus $7.39 11/05/20 Bristol-Myers raises FY20 EPS view to $6.25-$6.35 from $6.10-$6.25 11/05/20 Bristol-Myers reports Q3 EPS $1.63, consensus $1.49 11/04/20 Notable companies reporting before tomorrow's open BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 10/05/20 Bristol-Myers to buy MyoKardia for $13.1B, or $225/share in cash, WSJ reports BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks 11/05/20 Fly Intel: Pre-market Movers 10/08/20 Cytokinetics plunges following mixed results from heart drug trial 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 03/01/21 41st Annual Healthcare Virtual Conference 02/04/21 Bristol-Myers - BMY 02/20/21 PDUFA Date for OPDIVO / CABOMETYX bmy 03/27/21 PDUFA Date for Ide-Cel BMY Bristol-Myers $64.78 / +0.59 (+0.92%) 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish 01/04/21 Bristol Myers Squibb call buyer realizes 25% same-day gains
Technical Analysis	NASDAQ market internals summary » 13:17 01/22/21 01/22 13:17 01/22/21 13:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 01/21/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 13:16 01/22/21 01/22 13:16 01/22/21 13:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 01/21/21 NYSE market internals summary
Hot Stocks	Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO » 13:12 01/22/21 01/22 13:12 01/22/21 13:12 EXEL Exelixis $21.63 / +0.3 (+1.41%) Exelixis announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events EXEL Exelixis $21.63 / +0.3 (+1.41%) 12/21/20 Exelixis announces cabozantinib trial meets co-primary endpoint 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/07/20 Exelixis in-licenses Aurigene's novel CDK7 inhibitor, files IND 12/02/20 Exelixis exercises option for Iconic's ADC, to develop under May 2019 pact EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 12/14/20 William Blair Calithera risk/reward attractive into CANTATA readout, says William Blair 10/26/20 Piper Sandler Exelixis could have successor to Cabometyx with XL092, says Piper Sandler 09/22/20 Morgan Stanley Exelixis price target raised to $29 from $23 at Morgan Stanley EXEL Exelixis $21.63 / +0.3 (+1.41%) 01/10/21 Exelixis sees FY21 revenue $1.15B-$1.25B, consensus $1.16B 01/10/21 Exelixis reports preliminary Q4 revenue $270M, consensus $213.78M 11/05/20 Exelixis sees FY20 revenue $900M-$950M, consensus $922M 11/05/20 Exelixis reports Q3 adjusted EPS 4c, consensus 1c 03/01/21 41st Annual Healthcare Virtual Conference 02/20/21 PDUFA Date for OPDIVO / CABOMETYX bmy

Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs » 13:11 01/22/21 01/22 13:11 01/22/21 13:11 BKR Baker Hughes $22.15 / -0.41 (-1.82%) Baker Hughes reports that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $22.15 / -0.41 (-1.82%) 13:01 Today Baker Hughes reports U.S. rig count up 5 to 378 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $22.15 / -0.41 (-1.82%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $22.15 / -0.41 (-1.82%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $22.15 / -0.41 (-1.82%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $22.15 / -0.41 (-1.82%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit
Hot Stocks	Baker Hughes reports U.S. rig count up 5 to 378 rigs 13:01 01/22/21 01/22 13:01 01/22/21 13:01 BKR Baker Hughes $21.97 / -0.59 (-2.62%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/15/21 Baker Hughes reports U.S. rig count up 13 to 373 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs 01/08/21 Baker Hughes reports U.S. rig count up 9 to 360 rigs BKR Baker Hughes $21.97 / -0.59 (-2.62%) 09:18 Today Morgan Stanley Baker Hughes price target raised to $26 after earnings at Morgan Stanley 01/13/21 JPMorgan JPMorgan announces top 10 energy picks for 2021 01/08/21 Barclays Baker Hughes downgraded to Equal Weight from Overweight at Barclays 12/18/20 JPMorgan Baker Hughes price target raised to $23 from $20 at JPMorgan BKR Baker Hughes $21.97 / -0.59 (-2.62%) 01/21/21 Baker Hughes reports Q4 adjusted EPS (7c), consensus 17c 10/21/20 Baker Hughes reports Q3 EPS 4c, consensus 4c 10/20/20 Notable companies reporting before tomorrow's open 10/20/20 Notable companies reporting before tomorrow's open BKR Baker Hughes $21.97 / -0.59 (-2.62%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says BKR Baker Hughes $21.97 / -0.59 (-2.62%) 10/21/20 Fly Intel: Pre-market Movers 03/01/21 26th Annual Energy Virtual Summit
Upgrade	Icade upgraded to Buy from Hold at Deutsche Bank » 12:57 01/22/21 01/22 12:57 01/22/21 12:57 CDMGF Icade $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CDMGF Icade $0.00 / + (+0.00%) 01/19/21 Barclays Icade price target lowered to EUR 67 from EUR 68 at Barclays 11/09/20 Goldman Sachs Icade upgraded to Neutral from Sell at Goldman Sachs 10/23/20 Deutsche Bank Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank 10/20/20 BofA Icade upgraded to Buy from Neutral at BofA
Periodicals	Amazon files motion to halt union election at Alabama warehouse, Reuters says » 12:56 01/22/21 01/22 12:56 01/22/21 12:56 AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) Amazon has filed a motion… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/19/21 Amazon invests in five new facilities in Quebec, creates over 1,000 new jobs 01/15/21 FCA announced as first OEM to implement Amazon's new Alexa Custom Assistant 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Lion Electric CEO: We are not an overnight success AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 07:10 Today Credit Suisse Amazon.com price target raised to $3,860 from $3,750 at Credit Suisse 01/21/21 BofA Amazon.com price target raised to $4,000 from $3,650 at BofA 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/11/21 Baird Baird remains a buyer of Amazon ahead of Q4 results AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/14/21 Fly Intel: What to watch in first round of big bank earnings reports 10/29/20 Amazon.com sees Q4 revenue $112B-$121B, consensus $112.32B 10/29/20 Amazon.com reports Q3 EPS $12.37, consensus $7.41 07/30/20 Amazon.com sees Q3 sales $87B-$93B, consensus $86.29B AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/21/21 Judge sides with Amazon in Parler web-hosting case, NPR says 01/21/21 Parler loses request for injunction against Amazon, Bloomberg reports 01/20/21 Amazon's Twitch 'indefinitely' suspends Donald Trump, Verge says 01/20/21 Amazon says 'ready to assist' with COVID vaccination efforts, GeekWire reports AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 02/02/21 Amazon.com - AMZN AMZN Amazon.com $3,298.70 / -9.6 (-0.29%) 12/31/20 Unusually active option classes on open December 31st 12/29/20 Unusually active option classes on open December 29th 10/26/20 Early notable gainers among liquid option names on October 26th 08/18/20 Early notable gainers among liquid option names on August 18th
Recommendations	Sage Group price target lowered to 500 GBp from 530 GBp at Credit Suisse » 12:55 01/22/21 01/22 12:55 01/22/21 12:55 SGPYY Sage Group $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SGPYY Sage Group $0.00 / + (+0.00%) 01/14/21 Sage Group says AgeMark moves to Sage Intacct solution 12/16/20 Sage announces Sage Partner Cloud Program in the U.S., Canada SGPYY Sage Group $0.00 / + (+0.00%) 05:24 Today Peel Hunt Sage Group initiated with a Buy at Peel Hunt 01/11/21 Canaccord Sage Group price target lowered to 680 GBp from 700 GBp at Canaccord 12/10/20 Morgan Stanley Sage Group upgraded to Equal Weight from Underweight at Morgan Stanley 11/25/20 JPMorgan Sage Group price target lowered to 560 GBp from 600 GBp at JPMorgan

Recommendations	HelloFresh price target raised to EUR 81 from EUR 65 at Credit Suisse » 12:54 01/22/21 01/22 12:54 01/22/21 12:54 HLFFF HelloFresh $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HLFFF HelloFresh $0.00 / + (+0.00%) 01/21/21 Citi Citi opens positive 'Catalyst Watch' on HelloFresh, ups target to EUR 80 01/12/21 Berenberg HelloFresh price target raised to EUR 82 from EUR 68 at Berenberg 01/06/21 Morgan Stanley HelloFresh price target raised to EUR 66 from EUR 48 at Morgan Stanley 12/18/20 Barclays HelloFresh price target raised to EUR 70 from EUR 62 at Barclays
Recommendations	Sandvik AB price target raised to SEK 240 from SEK 215 at Credit Suisse » 12:54 01/22/21 01/22 12:54 01/22/21 12:54 SDVKY Sandvik AB $0.00 / + (+0.00%) Credit Suisse analyst Max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SDVKY Sandvik AB $0.00 / + (+0.00%) 01/15/21 Sandvik AB acquires minority stake in Oqton, terms undisclosed 12/24/20 Sandvik to acquire DSI Underground for approx. EUR943M 10/09/20 Sandvik AB to divest exploration business to Drillman SDVKY Sandvik AB $0.00 / + (+0.00%) 12:42 Today JPMorgan Sandvik AB price target raised to SEK 220 from SEK 215 at JPMorgan 01/19/21 UBS Sandvik AB downgraded to Neutral from Buy at UBS 01/19/21 Jefferies Sandvik AB upgraded to Buy from Hold at Jefferies 01/13/21 Barclays Sandvik AB price target raised to SEK 230 from SEK 160 at Barclays
Hot Stocks	Vuzix trading resumes 12:53 01/22/21 01/22 12:53 01/22/21 12:53 VUZI Vuzix $10.17 / -0.715 (-6.57%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options VUZI Vuzix $10.17 / -0.715 (-6.57%) 12:48 Today Vuzix trading halted, volatility trading pause 01/11/21 Vuzix confirms joint manufacturing and supply agreement with Jade Bird 12/29/20 Vuzix receives follow-on M400 Smart Glasses order 12/22/20 Vuzix enters supply agreement with large general merchandise retailer in U.S. VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/19/21 Maxim Vuzix price target raised to $13 from $6.50 at Maxim 09/04/20 Craig-Hallum Vuzix price target raised to $8 from $6 at Craig-Hallum 05/11/20 Alliance Global Partners Vuzix downgraded to Neutral from Buy at Alliance Global Partners VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/15/21 Vuzix reports preliminary Q4 revenue $4M, consensus $3.52M 11/09/20 Vuzix reports Q3 EPS (13c), consensus (12c) 08/10/20 Vuzix reports Q2 EPS (13c), consensus (15c) VUZI Vuzix $10.17 / -0.715 (-6.57%) 12/18/20 Citron says 'no way' would be shorting Vuzix VUZI Vuzix $10.17 / -0.715 (-6.57%) 01/19/21 Largest borrow rate increases among liquid names 01/13/21 Vuzix call volume above normal and directionally bullish 12/22/20 Vuzix call volume above normal and directionally bullish 12/18/20 Vuzix call volume above normal and directionally bullish
Recommendations	Adidas price target raised to EUR 255 from EUR 250 at Credit Suisse » 12:50 01/22/21 01/22 12:50 01/22/21 12:50 ADDYY Adidas $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly ADDYY Adidas $0.00 / + (+0.00%) 12/14/20 Adidas assessing strategic alternatives for Reebok, including potential sale 09/24/20 Kanye West demands Gap board seat before product releases 09/10/20 Kohl's launches Adidas active collection with actress Zoe Saldana ADDYY Adidas $0.00 / + (+0.00%) 01/13/21 Exane BNP Paribas Adidas upgraded to Outperform from Neutral at Exane BNP Paribas 11/16/20 Berenberg Adidas price target raised to EUR 310 from EUR 290 at Berenberg 11/13/20 RBC Capital Adidas downgraded to Sector Perform from Outperform at RBC Capital 11/11/20 Morgan Stanley Adidas price target raised to EUR 210 from EUR 195 at Morgan Stanley ADDYY Adidas $0.00 / + (+0.00%) 12/29/20 Reebok's $2.4B price tag brings new buyers to the table, Forbes reports 10/22/20 Adidas said to plan to sell Reebok business, Reuters reports ADDYY Adidas $0.00 / + (+0.00%) 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 09/22/20 Fly Intel: What to watch in Nike's earnings report
Hot Stocks	Vuzix trading halted, volatility trading pause 12:48 01/22/21 01/22 12:48 01/22/21 12:48 VUZI Vuzix $10.15 / -0.735 (-6.75%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/11/21 Vuzix confirms joint manufacturing and supply agreement with Jade Bird 12/29/20 Vuzix receives follow-on M400 Smart Glasses order 12/22/20 Vuzix enters supply agreement with large general merchandise retailer in U.S. 12/02/20 Vuzix announces follow-on order from Pixee Medical VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/19/21 Maxim Vuzix price target raised to $13 from $6.50 at Maxim 09/04/20 Craig-Hallum Vuzix price target raised to $8 from $6 at Craig-Hallum 05/11/20 Alliance Global Partners Vuzix downgraded to Neutral from Buy at Alliance Global Partners VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/15/21 Vuzix reports preliminary Q4 revenue $4M, consensus $3.52M 11/09/20 Vuzix reports Q3 EPS (13c), consensus (12c) 08/10/20 Vuzix reports Q2 EPS (13c), consensus (15c) VUZI Vuzix $10.15 / -0.735 (-6.75%) 12/18/20 Citron says 'no way' would be shorting Vuzix VUZI Vuzix $10.15 / -0.735 (-6.75%) 01/19/21 Largest borrow rate increases among liquid names 01/13/21 Vuzix call volume above normal and directionally bullish 12/22/20 Vuzix call volume above normal and directionally bullish 12/18/20 Vuzix call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

BIOL
Today at 14:00

Biolase Inc. Firm Sponsored Meetings

27042 Towne Centre Dr Suite 270, Foothill Ranch, CA
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
FDX
2021-01-25 at 00:00

FedEx Firm Sponsored Meetings

Virtual Meeting
NAVB
2021-01-25 at 00:00

Navidea Firm Sponsored Meetings

Virtual Meeting
NBAC
2021-01-25 at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting
USB
2021-01-25 at 00:00

U.S. Bancorp Firm Sponsored Meetings

Virtual Meeting
SEEL
2021-01-25 at 00:00

Seelos Therapeutics Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

ABB price target raised to CHF 22 from CHF 21.50 at JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access